The endocannabinoids and their main receptor CB1 suppress intracellular cyclic AMP levels and have emerged as key players in the control of energy metabolism. CB1 agonists and blockers have been reported to influence the thermogenic function of white and brown adipose tissue (WAT and BAT), affecting body weight through the inhibition and stimulation of energy expenditure, respectively. The purpose of the current study was to investigate the regulation of the endocannabinoid system in WAT and BAT following exposure to either cold or specific agonism of β3-adrenoceptors using CL316,243, conditions known to cause BAT activation and WAT browning. To address this question we performed qPCR-based mRNA profiling of genes important for endocannabinoid synthesis, degradation and signalling, and determined endocannabinoid levels by liquid chromatography-mass spectrometry in WAT and BAT of control, coldexposed and CL316,243-treated wildtype mice as well as primary brown adipocytes. Treatment with CL316,243 and exposure to cold caused an upregulation of endocannabinoid levels and biosynthetic enzymes in WAT. Acute β3-adrenoceptor activation increased endocannabinoids and a subset of genes of biosynthesis in BAT and primary brown adipocytes. We suggest that the cold-mediated increase in endocannabinoid tone is part of an autocrine negative feed-back mechanisms controlling β3-adrenoceptorinduced BAT activation and WAT browning.
Introduction
The recent discovery of active brown adipose tissue (BAT) in adult humans (1-3) is one of the most intriguing findings as it raises hope for the treatment of obesity and related chronic metabolic diseases. The natural function of BAT is to combust energy from high-caloric nutrients to defend the body against cold environments (4) . The ability to burn energy-dense triglycerides as fuels for heat production could enable BAT to diminish hypertrophic WAT depots, a prerequisite for the prevention of metabolic lifestyle diseases (5, 6) . In humans, BAT activity determined by PET-CT is positively correlated with BAT mass (1-3), BAT activation status (2) and environmental factors such as low temperatures (7) . Repeated cold exposure leads to increased BAT activity (8, 9) , a condition that is associated with a self-reported decrease in sensitivity to cold. The thermogenic process is dependent on the presence of uncoupling protein-1 (UCP1), a protein located in the inner membrane of mitochondria that is able to separate electron transport in the respiratory chain from the production of energy in form of ATP. The heat generated by this exothermic reaction is transported via the blood circulation system to maintain body temperature (10) . Low BAT activity in humans correlates with ageing and obesity (2, 11) , suggesting a causal link between decreased BAT activity, weight gain and the development of metabolic diseases. In this context, channeling fatty acids and triglycerides into BAT could attenuate deleterious effects that, e.g., saturated fatty acids cause by ectopic lipid accumulation in liver or heart. In fact, up to 90% of energy for heat production is derived from fatty acids that are delivered by triglyceride-rich lipoproteins (4, 10, 12) . These latter are hepatic very low density lipoproteins (VLDL) and intestinal chylomicrons that are both processed by endothelium-bound lipoprotein lipase to allocate fatty acids to BAT and energy storing white adipose tissue (WAT), respectively.
In response to cold exposure, both brown and white adipocytes are activated via sympathetic neurons that release noradrenalin (10) . Catecholamine release causes the activation of β3-adrenoceptor signaling stimulating lipolysis of triglycerides stored in lipid droplets, a process mediated by the enzymatic activity of adipose tissue triglyceride lipase (ATGL) and hormone sensitive lipase (HSL) (13) . In brown adipocytes, fatty acids are transferred to mitochondria for beta-oxidation and UCP-1-dependent heat production. In white adipocytes, lipid droplet derived fatty acids are released into the circulation for hepatic by guest, on October 1, 2017 www.jlr.org Downloaded from VLDL production to maintain energy supply for cold-activated brown adipocytes. Thus, short term activation of β3-adrenoceptors stimulates intracellular lipolysis orchestrating the systemic energy homeostasis. It is not surprising that both WAT and BAT undergo adaptive and dynamic changes in response to sustained β3-adrenoceptor activation or cold exposure. In this context one of the most intensively studied cell types implicated in cold-induced tissue remodeling in WAT (browning) is the so-called beige adipocyte (14) . Prolonged cold exposure or pharmacological treatment using β3-adrenoceptor agonists such as CL316,243 (CL) stimulate the development of these inducible brown-like adipocytes (14) (15) (16) (17) . Brown and beige adipocytes are characterized by a large number of mitochondria and numerous small lipid droplets and both cell types are functionally active with regard to adaptive thermogenesis (18).
The endocannabinoid system, and in particular the G-protein-coupled receptor known as cannabinoid receptor type-1 (CB1), and its endogenous agonists, N-arachidonoylethanolamine (anandamide, AEA) and 2-arachidonoylglycerol (2-AG), have emerged as major players in the control of metabolism at both the central and peripheral level (19). Importantly, malfunctioning of this system due to enhanced tissue levels of endocannabinoids and subsequent overactivation of CB1 receptors in the hypothalamus, visceral WAT, liver, muscle and pancreas, accompanies, and is probably one of the causes of, fat accumulation and insulin resistance in animal models of obesity. High plasmatic levels of endocannabinoids have been associated with increased cardiometabolic risk, visceral WAT accumulation and type 2 diabetes in obese patients (19). Genetic impairment of CB1 receptors selectively in neurons of the brain and sympathetic nervous system (SNS) enhances energy expenditure (EE) by the brown adipose tissue (20), and very recent evidence suggests an inhibitory role of prejunctional CB1 on brown adipocyte glucose utilization (21), thermogenesis and lipid droplet formation (22). Furthermore, CB1 blockade in Sim1-expressing neurons of the paraventricular nucleus of the hypothalamus enhances EE during high fat diet feeding (23). Whilst mice overexpressing neuropeptide Y on noradrenergic neurons of the brain and SNS exhibit age-dependent elevation of endocannabinoid levels in many target organs, including the WAT (24), genetic knockout of CB1 in Sim1-expressing neurons is accompanied by increased mRNA expression of the β3-adrenoceptor and UCP-1 in the BAT of high-fat diet-fed mice (23). These data point to a strong and SNS-mediated association between the endocannabinoid system and the control of BAT and WAT function. While there are several examples of reports (summarised in (19) pointing to an autocrine role of endocannabinoids and CB1 receptors on white adipocytes, facilitating, among others, also their transformation into beige adipocytes (25, 26), evidence for a similar role in brown adipocytes is still scant.
Through the use of a peripherally restricted CB1 antagonist in vivo, and of T37i brown adipocyte-like cells in vitro, Boon et al. [22] very recently suggested that some of the above effects of CB1 blockade in the BAT, and in particular the stimulation of uncoupled respiration, may be exerted post-junctionally and directly on brown adipocytes, most likely by enhancing cyclic AMP/PKA signaling induced by β3-adrenoceptor activation. However, the question whether exposure to cold, via sympathetic stimulation of β3-adrenoceptors in brown adipocytes, enhances endocannabinoid levels in BAT has not been tested so far.
In the present study, we addressed this hypothesis by examining the effect of cold exposure and pharmacological β3-adrenoceptor activation in mice using the selective agonist CL on: 1) the levels of AEA, 2-AG and non-endocannabinoid N-acylethanolamines (NAEs), and 2) mRNA expression levels of genes encoding for CB1 receptors and endocannabinoid metabolic enzymes (Fig. 1) . In order to analyse the effects on BAT activity as well as browning of subcutaneous WAT, these studies were conducted under conditions of acute and chronic cold and β3-adrenergic stimulation.
Methods

Experimental animals and diets
All animal experiments were approved by the Animal Welfare Officers of University Medical Center Hamburg-Eppendorf (UKE) and Behörde für Gesundheit und Verbraucherschutz Hamburg. Mice were bred and housed in the animal facility of UKE at 22°C-24°C with a day and night cycle of 12 hours. Male agematched (12-14 weeks) C57BL/6J WT mice, housed in single cages and fed a standard chow diet (Lasvendi) with ad libitum access to food and water were used for the experiments. Cold exposure was performed by housing mice at 6°C for 1 day or 7 days. The β 3-adrenoceptor agonist CL (Tocris, 0.2 mg CL316,243/mL in 0.9 w/v % NaCl) was administered by subcutaneous injection (1 μg per g body weight and day) either for by guest, on October 1, 2017 www.jlr.org Downloaded from a) 7 days without treatment on the day of necropsy (chronic CL), b) only once, 4 hours before necropsy (acute CL), or c) chronically for 7 days with an additional injection on day 8 before necropsy (chronic+acute CL). Mock-treated control mice and acute CL mice received corresponding 0.9 w/v % NaCl injections throughout the treatment period. All tissue and blood collections were performed after 4 h fasting. Mice were anesthetized with a lethal dose (15 µL/g mouse bodyweight) of a mix containing ketamine (25 mg/mL) / xylazine (0.2%) in 0.9% NaCl. Blood was withdrawn transcardially and animals were perfused with 5 mL ice-cold PBS containing 10 U/mL heparin. Organs were harvested, immediately frozen and stored at -80°C.
For RNA analysis samples were conserved in TRIzol ® reagent (Invitrogen).
Gene expression analysis
Total RNA was isolated from inguinal subcutaneous WAT and subscapular BAT using NucleoSpin RNA 
Extraction, purification and quantitative analysis of endocannabinoids from adipose tissue
Lipids were extracted from inguinal subcutaneous WAT and interscapular BAT of mice, and endocannabinoid purified from lipid extracts, as previously described (27). Measurement of 
Culture of primary brown adipocytes
For the preparation of primary brown adipocytes, 9 week old C57BL6/J mice were anesthetized, interscapular BAT was removed and digested in isolation buffer (123mM NaCl, 5mM KCl, 1.3mM CaCl2, Supernatants were harvested and non-esterified fatty acids were determined using standard colorimetric assays (Wako). RNA analysis of brown adipocytes was performed as described for the tissue samples.
Results
Effect of cold and β3-adrenoceptor activation on the expression of thermogenesis markers and endocannabinoid receptors in BAT and WAT
In order to study the endocannabinoid system in cold-activated BAT and WAT, and to differentiate shortterm from long-term effects, the following treatments were chosen: cold exposure was applied to mice for either one day (1d cold) or for 7 days (7d cold). To another set of mice the β3-adrenergic agonist CL was administered, either once, 4 hours before necropsy (acute CL), for seven consecutive days and also on day Stimulation of β3-adrenoceptors with CL and exposure to cold are known to markedly enhance the expression of characteristic markers of uncoupled respiration and thermogenesis via specific transcription factors in WAT and BAT (14, 15) , revealing different degrees of WAT browning and BAT activation, respectively ( Fig. 2) . In both tissues, activation of the respective signaling pathways induced mRNA levels of Ucp1 ( Fig. 2A, E) , which encodes the heat generating protein UCP1 that is located in the inner mitochondrial membrane of thermogenic adipocytes. In comparison to its expression in BAT, the basal (29), which encodes an enzyme converting inactive tetra-iodothyronine (T4) to active tri-iodothyronine (T3). In addition, we observed a profound induction of Elovl3 (Fig. 2D, H) , a fatty acid elongase specifically expressed in brown adipocytes during increased fatty acid oxidation (30) .
In both tissues, chronic+acute CL treatment but not any of the other treatments significantly stimulated the expression of Cnr1, the gene encoding for the CB1 endocannabinoid receptor (Fig. 2I, K) . Finally, in BAT but not WAT, acute CL as well as acute+chronic CL treatment, and 1 day exposure to cold, reduced the expression of Cnr2, the cannabinoid type-2 (CB2) receptor (Fig. 2J, L) , which was however based on total copy numbers less expressed than CB1 in both adipose tissues (data not shown).
The endocannabinoid system is induced in BAT by acute β3-adrenergic stimulation Both acute and chronic+acute CL treatment of the mice, but not chronic CL treatment per se, elevated the levels of the endocannabinoids 2-AG and AEA in BAT. The effect was statistically significant for AEA in both cases, however for 2-AG only with chronic+acute CL treatment. Cold exposure did not cause the same effect, although a trend was observed for AEA with a 1 day exposure (Fig. 3A, B) . Interestingly, acute and chronic+acute CL administration as well as short-term cold exposure caused a strong and significant elevation in the levels of the AEA congeners N-palmitoylethanolamine (PEA) and N-oleoylethanolamine (OEA) which was also present after one day and 7day cold exposure (Fig. 3C, D, table 1 ). Thus, short-term β3-adrenergic stimulation leads to increased levels of both CB1 agonists and non-endocannabinoid NAEs in BAT.
The mRNA expression of the 2-AG biosynthetic enzyme diacylglycerol lipase-α (Dagla) was significantly elevated by acute and chronic+acute CL, corresponding to the 2-AG concentrations observed in BAT (Fig.   4A ). In contrast, the isoform Daglb was down-regulated by short-term cold exposure, whereas no effect was observed with any of the treatments on the expression of the gene encoding for the 2-AG degrading enzyme monoglyceride lipase (Mgll) (Fig. 4A-C) . Surprisingly, the mRNA levels of the NAE biosynthetic enzymes alpha/beta domain containing-4 (Abhd4), glycerophosphodiester phosphodiesterase-1 (Gde1), N-acyl phosphatidylethanolamine phospholipase D (Napepld) and the degrading enzyme fatty acid amide hydrolase (Faah) did not mirror the AEA levels. Instead, they were all reduced by acute CL, whereas cold exposure elevated the mRNA levels of Abhd4 and Gde1 (Fig. 4D-G) .
WAT β3-adrenergic stimulation and browning are accompanied by upregulation of the endocannabinoid system Next, we asked whether β3-adrenergic stimulation or cold exposure has an effect on endocannabinoids in WAT. 2-AG levels were significantly elevated after chronic but not acute CL treatment and, to a smaller extent, after prolonged cold exposure (Fig. 5A, table 1 ). AEA concentrations in WAT were significantly enhanced by all treatments, the strongest effects being observed with prolonged cold exposure, and chronic+acute CL treatment (Fig. 5B) . As observed in BAT, the levels of OEA and PEA were enhanced by the treatments in a manner very similar to AEA, although the effect of chronic CL did not reach statistical significance for PEA (Fig. 5C, D) .
All treatments, except for acute cold exposure, produced a statistically significant upregulation of Dagla (Fig. 6A ) whereas these treatments (including acute cold exposure) produced an opposite, down-regulatory, effect on Daglb (Fig. 6B ). All chronic treatments enhanced the mRNA levels of Mgll (Fig. 6C) . The mRNAs for NAE biosynthetic enzymes appeared to be regulated by the treatments in a similar manner, with chronic CL and hence chronic+acute CL producing statistically significant up-regulation of Abhd4, Gde1 and Napepld, and long-term cold exposure causing significant up-regulation only of Abhd4 and Gde1 (Fig. 6D-F ). Faah expression was not altered by any treatment (Fig. 6G) . Maximum induction of Mgll, Abhd4 and Gde1 required chronic CL or cold stimulation suggesting that beige rather than white adipocytes regulate the endocannabinoid system in brownish WAT. Taken together, in WAT both endocannabinoids are increased by β3-adrenergic and cold stimulation, and this is linked to an upregulation of biosynthetic enzymes of both 2-AG and NAEs.
Acute β3-adrenoceptor activation induces the expression of Cnr1 and endocannabinoid metabolic enzymes in primary brown adipocytes Next, we asked whether the acute regulation of Cnr1 and endocannabinoid synthetic enzymes observed in BAT could be reproduced in brown adipocytes in vitro. Acute CL stimulation of primary brown adipocytes caused elevated lipolysis and thermogenic activation, as shown by up-regulation of free fatty acids in the supernatant and Ucp1 mRNA (Fig. 7A, B) . Furthermore, it led to strong and statistically significant mRNA up-regulation of Cnr1 as well as of Faah, Dagla and Daglb, with no effect on Mgll (Fig. 7C-G) . Abhd4, Gde1 and Napepld were significantly downregulated. These data show that most (Cnr1, Dagla, Mgll, Abhd4, Gde1, Napepld) but not all (the exceptions being Daglb and Faah) gene expression effects observed in activated BAT in vivo could be mimicked in brown adipocytes by acute CL treatment.
Discussion
In the present study, we have shown for the first time that activation of BAT and browning of WAT in mice cause upregulation of endocannabinoid levels and presumably endocannabinoid signaling via CB1 receptors in these tissues. Given that CB1 receptor stimulation leads to a decrease of cyclic AMP signaling, we hypothesize that the upregulation of endocannabinoids by thermogenic stimuli reported here constitutes a local autocrine negative feed-back control by endocannabinoids over β3-adrenoceptor-induced BAT activation and WAT browning, which could account in part for the previously demonstrated enhancement of thermogenesis and energy expenditure by CB1 receptor inverse agonists, both in animal models of obesity (21, 22) and in obese humans (31) .
In the BAT, cold was ineffective at elevating endocannabinoid signaling in a statistically significant manner, and treatment of mice with CL had to be acute in order to achieve a statistically significant elevation of 2-AG and/or AEA (Fig. 3) , and it had to be chronic to observe enhancement of Cnr1 expression (Fig. 2) .
It is possible that chronic β-adrenergic stimulation under cold exposure leads to the desensitization of those intracellular signals required to elevate endocannabinoid levels following an acute stimulation, whereas, instead, the effect on the expression of CB1 receptors requires prolonged stimulation of other β3-adrenoceptor-coupled intracellular signals. The reasons for these differences might also lie in the differential regulation of the expression of AEA and 2-AG metabolic enzymes in the two tissues, measured here by quantifying the levels of the mRNAs encoding for the corresponding proteins (Fig. 1) . In BAT, the effect (or lack thereof) of CL on AEA levels cannot be accounted for by effects on the mRNA expression of enzymes encoding for AEA biosynthesis from N-arachidonoyl-phosphatidyl-ethanolamines (NArPE) and inactivation to arachidonic acid (Fig. 4) . It is possible, therefore, that CL causes elevation of AEA levels by affecting the availability of its biosynthetic precursors, the NArPEs, which are produced by enzymes that
have not yet been molecularly characterized. In the case of 2-AG, instead, whilst Mgll was unchanged, Dagla was upregulated by acute and chronic+acute treatment with CL (Fig. 4) , thus mirroring the effects of the drug on 2-AG levels and suggesting that the latter effects might be a consequence of the former. Daglb was down-regulated by chronic+acute treatment with CL, suggesting that this enzyme does not play a role in 2-AG biosynthesis in the BAT of β3-adrenoceptor-treated animals. Importantly, when we acutely stimulated β3-adrenoceptors in mouse primary brown adipocytes, we found the same changes of the mRNA expression of AEA biosynthetic enzymes and Dagla and Mgll (Fig. 7) as those observed in the BAT in vivo (Fig. 4) , suggesting cell-autonomous regulation triggered by β-adrenergic signaling. Conversely, Faah and by guest, on October 1, 2017
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Daglb were regulated in an opposite manner. This finding indicates that also other cell types/tissue might contribute to the acute effects of CL observed in vivo. However, it must be emphasized that the overall impact on the brown adipocyte endocannabinoid system of β3-adrenoceptor stimulation, i.e. a strong activation, is likely to be similar both in vitro and in vivo, particularly as in isolated brown adipocytes such treatment also induced upregulation of Cnr1 mRNA expression. Unfortunately, we could not assess the levels of endocannabinoids in primary brown adipocytes because of the lack of sufficient cell mass to overcome the detection limits of our LC-MS method.
In WAT both acute and prolonged treatments with either CL or cold appeared to produce significant elevation of at least one of the two endocannabinoids (Fig. 5) , although, again, only chronic treatment enhanced Cnr1 mRNA expression (Fig. 2) . The expression of at least one of the possible biosynthetic enzymes for AEA was stimulated to varying degrees by both CL and cold (Fig. 6 ), thus potentially explaining why the levels of this endocannabinoid were increased by these treatments. Likewise, and, in this case, similar to what observed in the BAT, Dagla, opposite to Daglb, was upregulated by the same treatments that led to elevation of 2-AG levels (Fig. 6 ), pointing once again to the former enzyme as the one potentially responsible for increased 2-AG biosynthesis in browning WAT. In summary, differential changes in the expression of endocannabinoid metabolic enzymes, induced by β3-adrenergic receptor stimulation by either a synthetic agonist or cold, might underlie in part by the different effects of these stimuli in activated BAT and browning WAT. Differences between AEA and 2-AG regulation might reflect the fact that these two endocannabinoids have also additional targets apart from CB1 and CB2 receptors (32) .
Slight differences in the effects of β3-adrenoceptor stimulation on the expression of AEA and NAE metabolic enzymes might also explain why, both in the BAT and WAT, the levels of PEA and OEA were more often elevated in a statistically significant manner than those of AEA. For example, in the BAT, cold elevated the levels of these two NAEs possibly due to its stimulatory action on the mRNA levels of Abhd4 were reported to act on other targets of potential importance for the regulation of adipose tissue metabolism, i.e. PPARα, TRPV1 (33) , and GPR55 (in the case of PEA) or GPR119 (in the case of OEA) (34, 35) .
Therefore, the role of these two mediators in the control of BAT activation and WAT browning will have to be fully assessed when the function of their proposed receptors in this context is further clarified.
Interestingly, conditional knockout of Napepld in the WAT was recently shown to reduce PEA and OEA, but not AEA, levels and to down-regulate Ucp1 expression in this tissue, suggesting a possible stimulatory role of either or both these compounds on WAT browning (36).
The other major target for AEA and, particularly, 2-AG, i.e. the CB2 receptor, appeared to be regulated by CL and cold exposure in the BAT in a manner opposite to CB1 receptors and/or endocannabinoid levels. Unlike CB1, the role of CB2 in the WAT, and particularly the BAT, has hardly been investigated, and hence future studies will have to address this issue through the use of selective CB2
agonists and antagonists as well as CB2 null mice.
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